FGROX | VEXRX | FGROX / VEXRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 23 years | - |
Gain YTD | 14.077 | 12.651 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 973M | 22B | 4% |
Annual Yield % from dividends | 0.00 | 0.58 | - |
Returns for 1 year | 26.96 | 26.37 | 102% |
Returns for 3 years | -30.10 | -20.66 | 146% |
Returns for 5 years | 5.40 | 18.31 | 29% |
Returns for 10 years | 41.32 | 18.71 | 221% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BITQ | 19.17 | 0.52 | +2.79% |
Bitwise Crypto Industry Innovators ETF | |||
FLGB | 26.66 | 0.03 | +0.11% |
Franklin FTSE United Kingdom ETF | |||
SPTS | 29.02 | 0.03 | +0.10% |
SPDR® Portfolio Short Term Treasury ETF | |||
AGNG | 30.82 | -0.30 | -0.95% |
Global X Aging Population ETF | |||
CNCR | 13.39 | -0.86 | -6.05% |
Range Cancer Therapeutics ETF |